Targeting Epigenetic Programs in MLL-Rearranged Leukemias
Open Access
- 10 December 2011
- journal article
- review article
- Published by American Society of Hematology in Hematology-American Society Hematology Education Program
- Vol. 2011 (1), 354-360
- https://doi.org/10.1182/asheducation-2011.1.354
Abstract
Rearrangements of the Mixed-Lineage Leukemia (MLL) gene are found in > 70% of infant leukemia, ∼ 10% of adult acute myelogenous leukemia (AML), and many cases of secondary acute leukemias. The presence of an MLL rearrangement generally confers a poor prognosis. There are more than 60 known fusion partners of MLL having some correlation with disease phenotype and prognosis. The most common fusion proteins induce the inappropriate expression of homeotic (Hox) genes, which, during normal hematopoiesis, are maintained by wild-type MLL. MLL-rearranged leukemias display remarkable genomic stability, with very few gains or losses of chromosomal regions. This may be explained by recent studies suggesting that MLL-rearranged leukemias are largely driven by epigenetic dysregulation. Several epigenetic regulators that modify DNA or histones have been implicated in MLL-fusion driven leukemogenesis, including DNA methylation, histone acetylation, and histone methylation. The histone methyltransferase DOT1L has emerged as an important mediator of MLL-fusion–mediated leukemic transformation. The clinical development of targeted inhibitors of these epigenetic regulators may therefore hold promise for the treatment of MLL-rearranged leukemia.Keywords
This publication has 82 references indexed in Scilit:
- Improved outcome with hematopoietic stem cell transplantation in a poor prognostic subgroup of infants with mixed-lineage-leukemia (MLL)–rearranged acute lymphoblastic leukemia: results from the Interfant-99 StudyBlood, 2010
- Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective studyPublished by American Society of Hematology ,2009
- MLL translocations, histone modifications and leukaemia stem-cell developmentNature Reviews Cancer, 2007
- Definitive Hematopoiesis Requires the Mixed-Lineage Leukemia GeneDevelopmental Cell, 2004
- Molecular mechanisms of leukemogenesis mediated by MLL fusion proteinsOncogene, 2001
- Altered Hox expression and segmental identity in Mll-mutant miceNature, 1995
- Acute mixed-lineage leukemia t(4;11)(q21;q23) generates an MLL-AF4 fusion product.Proceedings of the National Academy of Sciences of the United States of America, 1993
- The t(4;11) chromosome translocation of human acute leukemias fuses the ALL-1 gene, related to Drosophila trithorax, to the AF-4 geneCell, 1992
- Involvement of a homolog of Drosophila trithorax by 11q23 chromosomal translocations in acute leukemiasCell, 1992
- Identification of a gene, MLL, that spans the breakpoint in 11q23 translocations associated with human leukemias.Proceedings of the National Academy of Sciences of the United States of America, 1991